4//SEC Filing
Virgin Herbert 4
Accession 0001209191-22-045230
CIK 0001706431other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:50 PM ET
Size
10.8 KB
Accession
0001209191-22-045230
Insider Transaction Report
Form 4
Virgin Herbert
EVP, Research & CSO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-08-09−7,916→ 125,416 totalExercise: $10.39Exp: 2029-07-12→ Common Stock (7,916 underlying) - Exercise/Conversion
Common Stock
2022-08-09$1.53/sh+70,177$107,371→ 254,584 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-08-09−70,177→ 140,328 totalExercise: $1.53Exp: 2028-01-26→ Common Stock (70,177 underlying) - Exercise/Conversion
Common Stock
2022-08-09$10.39/sh+7,916$82,287→ 262,500 total
Footnotes (2)
- [F1]The option is fully vested and exercisable.
- [F2]1/4 of the shares subject to the stock option vested and become exercisable on July 12, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001786378
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:50 PM ET
- Size
- 10.8 KB